Donald Bergstrom
Chief Tech/Sci/R&D Officer presso RELAY THERAPEUTICS, INC.
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Donald A.
Bergstrom is currently an Independent Director at Cellectis SA, a Director at Cellectis, Inc., an Independent Director at Fusion Pharmaceuticals, Inc., and the President-Research & Development at Relay Therapeutics, Inc. He previously served as the Chief Medical Officer & Senior Vice President at Mersana Therapeutics, Inc. from 2014 to 2018 and as the Global Head-Translational & Experimental Medicine at Sanofi-Aventis U.S.
LLC from 2010 to 2014.
He also worked as a Principal at Merck Research Laboratories Massachusetts LLC.
Dr. Bergstrom holds a doctorate degree from the University of Washington and an undergraduate degree from The Johns Hopkins University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
RELAY THERAPEUTICS, INC.
0.40% | 27/03/2024 | 530 113 ( 0.40% ) | 4 M $ | 31/03/2024 |
14/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Donald Bergstrom
Società | Posizione | Inizio |
---|---|---|
RELAY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2018 |
FUSN PHAR | Director/Board Member | 01/04/2021 |
CELLECTIS S.A. | Director/Board Member | 28/06/2022 |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Director/Board Member | - |
Precedenti posizioni note di Donald Bergstrom
Società | Posizione | Fine |
---|---|---|
MERSANA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2018 |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2014 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | - |
Formazione di Donald Bergstrom
University of Washington | Doctorate Degree |
The Johns Hopkins University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
MERSANA THERAPEUTICS, INC. | Health Technology |
CELLECTIS S.A. | Health Technology |
RELAY THERAPEUTICS, INC. | Health Technology |
FUSN PHAR | Health Technology |
Aziende private | 3 |
---|---|
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Cellectis, Inc.
Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The private company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Health Technology |
- Borsa valori
- Insiders
- Donald Bergstrom